Avenue Therapeutics, Inc. Stock
Stocks
ATXI
US05360L4032
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3300 USD | +8.20% |
|
+17.86% | -51.48% |
| Market Cap | 1.09M 952K 877K 813K 1.54M 103M 1.57M 10.52M 4.09M 50.93M 4.08M 3.99M 176M | P/E 2024 |
-0.22x | P/E 2025 | -0.73x |
|---|---|---|---|---|---|
| Enterprise Value | -1.77M -1.55M -1.43M -1.32M -2.51M -168M -2.55M -17.09M -6.65M -82.8M -6.64M -6.49M -286M | EV / Sales 2024 |
-
| EV / Sales 2025 | -491,128x |
| Free-Float |
86.49% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +8.20% | ||
| 1 week | +17.86% | ||
| Current month | +17.86% | ||
| 1 month | -6.38% | ||
| 3 months | -5.71% | ||
| 6 months | -56.00% | ||
| Current year | -51.48% |
| 1 week | 0.25 |  | 0.33 |
| 1 month | 0.25 | | 0.36 |
| Current year | 0.15 | | 0.79 |
| 1 year | 0.15 | | 0.97 |
| 3 years | 0.15 | | 93.75 |
| 5 years | 0.15 | | 2,767.51 |
| 10 years | 0.15 | | 13,882.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 59 | 2022-07-31 | |
David Jin
CEO | Chief Executive Officer | 36 | 2022-03-30 |
Jaclyn Jaffe
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 2015-02-08 | |
Neil Herskowitz
BRD | Director/Board Member | 69 | 2015-07-31 |
Jay Kranzler
CHM | Chairman | 68 | 2023-03-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01-01 | Free | Company | 111,209 | 3.4934% | ||
| 25-03-30 | Free | Company | 33,724 | 1.6419% | ||
| 24-12-30 | Other | Company | 294,800 | 15.4214% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +8.20% | +17.86% | +3.51% | -99.61% | 1.09M | |
| -0.81% | +1.51% | +73.58% | +129.12% | 57.72B | |
| -3.80% | -6.24% | +67.04% | +86.36% | 52.65B | |
| +1.17% | +5.83% | +16.39% | +468.18% | 24.46B | |
| +0.38% | +1.33% | -14.32% | -11.76% | 23.84B | |
| -3.05% | +3.06% | +42.36% | -5.66% | 19.28B | |
| -0.33% | +5.21% | +44.38% | -26.55% | 17.8B | |
| +3.46% | +17.72% | +206.66% | +364.07% | 17.29B | |
| -6.73% | +9.90% | +36.04% | - | 15.28B | |
| +2.79% | +4.91% | +29.26% | +195.60% | 14.35B | |
| Average | +0.13% | +4.64% | +50.49% | +122.19% | 24.27B | |
| Weighted average by Cap. | -1.14% | +2.58% | +57.63% | +139.35% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 1.4 1.23 1.13 1.05 1.99 133.25 2.02 13.58 5.28 65.76 5.27 5.16 227.3 |
| Net income | -11.65M -10.2M -9.4M -8.71M -16.53M -1.11B -16.8M -113M -43.82M -546M -43.75M -42.8M -1.89B | -2.91M -2.55M -2.35M -2.17M -4.13M -276M -4.19M -28.13M -10.94M -136M -10.92M -10.68M -471M |
| Net Debt | -2.59M -2.27M -2.09M -1.94M -3.68M -246M -3.74M -25.09M -9.76M -122M -9.74M -9.53M -420M | -2.86M -2.5M -2.3M -2.13M -4.05M -271M -4.12M -27.61M -10.74M -134M -10.72M -10.49M -462M |
Employees
1
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-06 | US$0.3300 | +8.20% | 3,181 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATXI Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
